Author:
FUNATSU T.,IWATSUKI Y.,KAKU S.
Reference8 articles.
1. Novel factor Xa inhibitors for prevention and treatment of thromboembolic diseases;Kubitza;Expert Opin Investig Drugs,2006
2. Biochemical and pharmacological profile of darexaban, an oral direct factor Xa inhibitor;Iwatsuki;Eur J Pharmacol,2011
3. YM150, an oral direct inhibitor of factor Xa, demonstrated a predictable and dose-proportional pharmacokinetic/pharmacodynamic profile after single and multiple dosing: results from three studies;Groenendaal;Blood,2010
4. Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor;Kubitza;Clin Pharmacol Ther,2005
5. Apixaban metabolism and pharmacokinetics after oral administration to humans;Raghavan;Drug Metab Dispos,2009
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献